Adaptive regulation of alanine transport in hepatic plasma membrane vesicles from the endotoxin-treated rat
| Autor: | Thomas R. Austgen, Wiley W. Souba, Anthony J. Pacitti |
|---|---|
| Rok vydání: | 1991 |
| Předmět: |
Male
medicine.medical_specialty medicine.medical_treatment Biology In vivo Internal medicine Nucleotidase Escherichia coli medicine Animals Membrane vesicle Saline Alanine Alanine transport Vesicle Cell Membrane Biological Transport Rats Inbred Strains Intracellular Membranes Adaptation Physiological Rats Endotoxins Microscopy Electron medicine.anatomical_structure Endocrinology Liver Hepatocyte Surgery |
| Zdroj: | Journal of Surgical Research. 51:46-53 |
| ISSN: | 0022-4804 |
| DOI: | 10.1016/0022-4804(91)90068-w |
| Popis: | The mechanisms by which hepatic alanine consumption is increased during endotoxemia were investigated to gain further insight into the altered amino acid metabolism which characterizes critical illness. Rats were studied 12 hr after receiving endotoxin (ENDO) or saline. Hepatic alanine delivery was determined in vivo and hepatic alanine content was measured. Hepatocyte transport activity was studied by evaluation of [3H]-alanine accumulation in hepatocyte plasma membrane vesicles (HPMVs). Vesicle integrity was demonstrated by electron microscopy and a 14-fold enrichment in 5'-nucleotidase. Endotoxin treatment resulted in a state of hyperalaninemia and a threefold increase in hepatic alanine delivery (2.79 +/- 0.17 mu mole/100 g body weight/min in controls vs 8.13 +/- 0.98 in ENDO animals; P less than 0.001). Data from HPMVs revealed the presence of a high- and low-affinity component of alanine transport. Endotoxin treatment resulted in a 30% decrease in the Vmax of the high-affinity transport component (3355 +/- 177 pmole/mg protein/10 sec in controls vs 2338 +/- 270 in the ENDO group; P less than 0.05). Concomitant with the observed changes in alanine delivery and transport activity, endotoxin treatment resulted in a 56% rise in hepatic alanine content (2.53 +/- 0.29 mu mole/g liver in controls vs 3.95 +/- 0.23 in ENDO; P less than 0.005). These data indicate that the accelerated hepatic alanine consumption which occurs during endotoxemia is primarily the result of increased hepatic substrate delivery. Despite the resultant repression of transport activity, delivery begins to outdistance the metabolic capacity of the hepatocyte to utilize alanine and intracellular alanine levels rise. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|